Exelixis Email & Phone number of top level executives

Exelixis

Healthcare, Pharmaceuticals, and Biotech

Exelixis is a United States-based biopharmaceutical company that focuses on the development and commercialization of therapies for cancer treatments. Founded in 1994, the company specializes in creating small molecule drugs that target specific molecular pathways involved in cancer cell growth and proliferation. Exelixis has developed several approved therapies, including cabozantinib for the treatment of advanced kidney cancer and third-line advanced hepatocellular carcinoma, and another drug for the treatment of multiple types of advanced solid tumors. The company is committed to advancing cancer treatment options and providing hope to patients and their families fighting against devastating diseases.